In the past two years, the Food and Drug Administration has approved two novel Alzheimer's therapies, based on data from clinical trials showing that both drugs slowed the progression of the disease.

Private investment in pharmaceutical research can't replace the NIH. Both public investment and the private sector are needed ...

The National Institutes of Health proposal would limit indirect costs for research projects to 15 percent of grants.

With funding from the NIH earmarked by the Autism CARES Act, researchers aim to pinpoint the environmental factors that ...

This is seismic,” said Dr. Colin Duckett, vice dean for basic and preclinical science at the Duke University School of ...

Cancer researcher Karen Sfanos says she is 'terrified' of the impact of cuts to NIH funding that supports vital biomedical ...

Here’s a look at what the Trump administration’s decision to cut overhead funding for biomedical research means for ...

Changes to a key funding formula will reduce research grants at hospitals and universities by billions — and may discourage ...

Dr. Ashish Jha, dean of Brown University's School of Public Health, joins WBUR's Morning Edition to discuss the Trump administration's efforts to cap some funding for institutions that host medical ...

New research grant funding rules reportedly instituted by Elon Musk's DOGE would have profound impacts on San Diego, where a large number of academic institutions, pharmaceutical, and biotech ...